5 hepatology updates from ACG
Click Here to Manage Email Alerts
Several developments in hepatology were presented at the American College of Gastroenterology Annual Scientific Meeting in Las Vegas last month. Experts gathered to discuss transplantation, non-alcoholic fatty liver disease and more.
In case you missed it, Healio.com/Hepatology compiled five important highlights from the meeting. Be sure to follow us on Twitter @HealioHep for The Liver Meeting this month.
NASH surpasses HCV as top etiology for adults listed for liver transplant
LAS VEGAS — Nonalcoholic steatohepatitis is the number one etiology of liver disease among adults under the age of 50 years listed for liver transplantation, surpassing hepatitis C virus infection, according to findings presented at ACG 2016. Read more
Coffee protects against, genetics increase risk for alcoholic hepatitis in drinkers
LAS VEGAS — “Alcoholic hepatitis remains a highly fatal condition. … Regular coffee drinking protects against whereas PNPLA3 G allele increases risk of alcoholic hepatitis among heavy drinkers. Heavy drinkers with PNPLA3 G/G genotype who are not regular coffee drinkers are at the highest risk for alcoholic hepatitis,” Naga P. Chalasani, MD, FACG, professor of gastroenterology and hepatology at Indiana University School of Medicine, said during his presentation. Read more
Vitamin D linked to severe NAFLD
LAS VEGAS — Vitamin D levels are inversely associated with nonalcoholic fatty liver disease severity, per data presented in a liver plenary session at ACG 2016.
“Vitamin D level was inversely related to the degree of steatosis and liver fibrosis among NAFLD patients based on the liver ultrasound findings,” Hyun-seok Kim, MD, MPH, resident at Rutgers New Jersey Medical School, said during his presentation. Read more
USPSTF recommendation for HCV antibody testing finds prevalence in baby boomers
LAS VEGAS — The United States Preventive Services Task Force’s recommendation to perform hepatitis C virus antibody testing in adults born between 1945 and 1965, also known as baby boomers, is effective for the detection of HCV prevalence in this group, according to findings presented at ACG 2016. Read more
Using cardiac stents increases bleeding in patients with cirrhosis and CAD
LAS VEGAS — Patients with cirrhosis and coronary artery disease treated with coronary stents had an increased rate of gastrointestinal bleeding vs. patients with coronary artery disease treated via medical management, according to Timothy Krill, MD, department of internal medicine, University of Texas Southwestern Medical Center. Read more